Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan
暂无分享,去创建一个
K. Tamura | M. Matsuoka | K. Imai | T. Maeda | Y. Kitagawa | Toshimitsu Ito | S. Tabata | K. Miyoshi | M. Nagura-Ikeda | K. Kubota | S. Noguchi